Za. Scott et al., Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infants, J IMMUNOL, 167(12), 2001, pp. 7134-7140
Early potent combination antiretroviral therapies (ART) for HIV-1 infection
can preserve or restore immune function, but control of viral replication
early in infection may interfere with the development of HIV-1-specitic imm
une responses. Using an IFN-gamma ELISPOT assay, ive evaluated the breadth
and intensity of HIV-1-specific CD8(+) T cell responses in 17 vertically in
fected infants who began ART at 1-23 mo of age. CW-specific responses were
also characterized in three infants coinfected with HIV-1 and CMV. Before A
RT, HIV-1-specific CD8(+) T cell responses were detected in two of 13 (15%)
infants <6 mo of age. HIV-1-specific CD8(+) T cells became undetectable in
these two infants after the control of viral replication. Intermittent HIV
-1-specific responses were noted in six infants who did not experience dura
ble control of viral replication. In contrast, HIV-1-specific responses wer
e detected before ART in four of four infants >6 mo of age and became persi
stently undetectable in only one child. CMV-specific CD8(+) T cell response
s were persistently detected in all HIV-1 and CMV coinfected infants. In co
nclusion, HIV-1-specific CD8(+) T cell responses were less commonly detecte
d before therapy in young infants than in older infants. Suppression of vir
al replication appeared to interfere with the development and maintenance o
f HIV-1-specific CD8(+) T cell responses. The detection of CMV-specific res
ponses in HIV-1 and CMV coinfected infants suggests a selective defect in t
he generation or maintenance of HIV-1-specific CD8(+) T cell responses. The
rapeutic HIV-1 vaccine strategies in young infants may prolong the clinical
benefit of ART by expanding the HIV-1-specific CD8(+) T cell pool.